Robert B. Pelletier
Plus aucun poste en cours
Profil
Robert B.
Pelletier worked as a Senior Director & Chief Accounting Officer at EPIX Pharmaceuticals, Inc. from 2006 to 2006.
Prior to that, he was a Senior Director-Finance at The Medicines Co. from 2000 to 2003.
He also served as Vice President-Finance at AverStar, Inc. and as Principal Accounting Officer & VP-Finance at Panacos Pharmaceuticals, Inc. from 2006 to 2011.
Pelletier received his undergraduate degree from the University of Rhode Island and his MBA from Bentley University.
Anciens postes connus de Robert B. Pelletier
| Sociétés | Poste | Fin |
|---|---|---|
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Directeur/Membre du Conseil | 10/08/2006 |
| THE MEDICINES COMPANY | Directeur Financier/CFO | 01/03/2003 |
AverStar, Inc.
 AverStar, Inc. Packaged SoftwareTechnology Services AverStar, Inc. is a company based in Burlington, MA that specializes in [description not provided]. AverStar, Inc. has subsidiaries in the United States. AverStar was acquired by The Titan Corp. on June 27, 2000 for $140 million. | Directeur Financier/CFO | - |
| PANACOS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 16/02/2011 |
Formation de Robert B. Pelletier
| Bentley University | Masters Business Admin |
| University of Rhode Island | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
AverStar, Inc.
AverStar, Inc. Packaged SoftwareTechnology Services AverStar, Inc. is a company based in Burlington, MA that specializes in [description not provided]. AverStar, Inc. has subsidiaries in the United States. AverStar was acquired by The Titan Corp. on June 27, 2000 for $140 million. | Technology Services |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
